Research and Development Department, Hangzhou Wahaha Group Co., Ltd., Hangzhou 310018, China.
Key Laboratory of Food and Biological Engineering of Zhejiang Province, Hangzhou 310018, China.
Nutrients. 2023 Sep 3;15(17):3852. doi: 10.3390/nu15173852.
A gradual decline in cognitive function occurs with age. Accumulating evidence suggests that certain probiotic strains exert beneficial effects on age-related cognitive decline. Our previous study revealed that WHH1889 attenuated symptoms of anxiety and depression in depressed mice via shaping the 5-hydroxytryptamine (5-HT) and 5-hydroxytryptophan (5-HTP) metabolism and gut microbial community, indicating the psychobiotic potential of WHH1889. In the present study, the effects of WHH1889 on age-related cognitive decline were investigated. WHH1889 was orally administrated (1 × 10 CFU/day) for twelve weeks in aged mice, and their cognitive behaviors, neurochemical factors, cognitive-related gene expressions, neuroinflammation, and serum tryptophan pathway-targeted metabolic profiling, as well as gut microbiome composition were assessed. WHH1889 demonstrated improvement of the cognitive behaviors via the novel object recognition test (NORT), the active shuttle avoidance test (ASAT), the Y-maze test, and the passive avoidance test (PAT). The hippocampal neuronal loss; the declined concentrations of BDNF, 5-HT, and 5-HTP; the decreased gene expressions of neurodegeneration biomarkers; and the increased production of hippocampal inflammatory cytokines in aged mice were restored by WHH1889. In addition, WHH1889 increased the 5-HT/5HTP levels and decreased the serum levels of tryptophan-derived metabolites (e.g., kynurenine, xanthurenic acid, 3-hydroxykynurenine, and 3-hydroxyanthranilic acid). Furthermore, WHH1889 was revealed to shape the gut microbiota community by reversing the relative abundances of Bacteroidota and Firmicutes. The present findings suggest that WHH1889 exerted cognitive improving effects on aged mice, which was associated with the modulation of 5-HT and 5-HTP metabolism and gut microbial composition. The supplementation of WHH1889 may therefore be a promising therapeutic agent for age-related cognitive deficits.
认知功能随年龄逐渐下降。越来越多的证据表明,某些益生菌菌株对与年龄相关的认知能力下降具有有益影响。我们之前的研究表明,WHH1889 通过塑造 5-羟色胺(5-HT)和 5-羟色氨酸(5-HTP)代谢和肠道微生物群落,减轻了抑郁小鼠的焦虑和抑郁症状,表明 WHH1889 具有心理生物潜力。在本研究中,研究了 WHH1889 对与年龄相关的认知能力下降的影响。WHH1889 在老年小鼠中口服给予(每天 1×10 CFU)12 周,评估其认知行为、神经化学因子、认知相关基因表达、神经炎症和血清色氨酸途径靶向代谢谱以及肠道微生物组组成。WHH1889 通过新物体识别测试(NORT)、主动穿梭回避测试(ASAT)、Y 迷宫测试和被动回避测试(PAT)改善了认知行为。WHH1889 恢复了老年小鼠海马神经元丢失;BDNF、5-HT 和 5-HTP 浓度降低;神经退行性生物标志物的基因表达降低;海马炎性细胞因子产生增加。此外,WHH1889 增加了 5-HT/5-HTP 水平,降低了血清中色氨酸衍生代谢物(如犬尿氨酸、黄尿酸、3-羟基犬尿氨酸和 3-羟基邻氨基苯甲酸)的水平。此外,WHH1889 通过逆转 Bacteroidota 和 Firmicutes 的相对丰度来塑造肠道微生物群落。本研究结果表明,WHH1889 对老年小鼠具有认知改善作用,这与 5-HT 和 5-HTP 代谢和肠道微生物组成的调节有关。因此,WHH1889 的补充可能是治疗与年龄相关的认知功能障碍的有前途的治疗剂。